Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens

@inproceedings{Pan2018RecentDA,
  title={Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens},
  author={Ren-You Pan and Wen-Hung Chung and Mu-Tzu Chu and Shu-Jen Chen and Hua-Chien Chen and Lei Zheng and Shuen-Iu Hung},
  booktitle={Journal of immunology research},
  year={2018}
}
Recently, increasing data show that immunotherapy could be a powerful weapon against cancers. Comparing to the traditional surgery, chemotherapy or radiotherapy, immunotherapy more specifically targets cancer cells, giving rise to the opportunities to the patients to have higher response rates and better quality of life and even to cure the disease. Cancer vaccines could be designed to target tumor-associated antigens (TAAs), cancer germline antigens, virus-associated antigens, or tumor… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 81 REFERENCES

Non-small cell lung cancer: current treatment and future advances.

  • Translational lung cancer research
  • 2016
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Classification of current anticancer immunotherapies

  • Oncotarget
  • 2014
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Genetic cancer vaccines: current status and perspectives.

  • Expert opinion on biological therapy
  • 2012
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2019
VIEW 2 EXCERPTS

CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape.

  • Molecular therapy : the journal of the American Society of Gene Therapy
  • 2017
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…